AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
189.90
+97.13 (104.70%)
Feb 2, 2026, 1:56 PM EST - Market open
AstraZeneca Employees
AstraZeneca had 92,900 employees as of December 31, 2024. The number of employees increased by 3,000 or 3.34% compared to the previous year.
Employees
92,900
Change (1Y)
3,000
Growth (1Y)
3.34%
Revenue / Employee
$625,694
Profits / Employee
$101,173
Market Cap
289.37B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 92,900 | 3,000 | 3.34% |
| Dec 31, 2023 | 89,900 | 6,400 | 7.66% |
| Dec 31, 2022 | 83,500 | 400 | 0.48% |
| Dec 31, 2021 | 83,100 | 7,000 | 9.20% |
| Dec 31, 2020 | 76,100 | 5,500 | 7.79% |
| Dec 31, 2019 | 70,600 | 6,000 | 9.29% |
| Dec 31, 2018 | 64,600 | 3,500 | 5.73% |
| Dec 31, 2017 | 61,100 | 1,400 | 2.35% |
| Dec 31, 2016 | 59,700 | -1,800 | -2.93% |
| Dec 31, 2015 | 61,500 | 4,000 | 6.96% |
| Dec 31, 2014 | 57,500 | 6,000 | 11.65% |
| Dec 31, 2013 | 51,500 | -200 | -0.39% |
| Dec 31, 2012 | 51,700 | -5,500 | -9.62% |
| Dec 31, 2011 | 57,200 | -3,800 | -6.23% |
| Dec 31, 2010 | 61,000 | -1,700 | -2.71% |
| Dec 31, 2009 | 62,700 | -2,300 | -3.54% |
| Dec 31, 2008 | 65,000 | -2,400 | -3.56% |
| Dec 31, 2007 | 67,400 | 600 | 0.90% |
| Dec 31, 2006 | 66,800 | 1,500 | 2.30% |
| Dec 31, 2005 | 65,300 | 1,100 | 1.71% |
| Dec 31, 2004 | 64,200 | 1,600 | 2.56% |
| Dec 31, 2003 | 62,600 | 3,400 | 5.74% |
| Dec 31, 2002 | 59,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| Sanofi | 82,878 |
| Pfizer | 81,000 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| GSK plc | 68,629 |
| AbbVie | 55,000 |
AZN News
- 6 hours ago - AstraZeneca begins trading on the New York Stock Exchange - Business Wire
- 1 day ago - AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation - CNBC
- 3 days ago - AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China's CSPC - WSJ
- 3 days ago - World leaders descend on Beijing as 2026 kicks off, hedging against U.S. disruptions - CNBC
- 3 days ago - China's CSPC Pharmaceutical inks deal with AstraZeneca for weight loss therapy - Reuters
- 4 days ago - AstraZeneca sets out $15 billion China investment during Starmer visit - Reuters
- 4 days ago - University of Virginia Signs Master Research Collaboration Agreement with AstraZeneca to Accelerate Pre-Clinical Innovation - GlobeNewsWire
- 5 days ago - Airbus, AstraZeneca and HSBC executives join UK's Starmer on high-stakes China trip - CNBC